{
  "retracted": false,
  "timestamp": 1476144000000,
  "updates": [
    {
      "timestamp": 1585251093043,
      "identifier": {
        "doi": "10.1038/bjc.2016.342"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/bjc.2016.271"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer"
}
